Characteristics of retinal vein occlusion (RVO) patients with macular edema who lasted remission more than 6 months after single injection of intravitreal bevacizumab

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|94|S256|j.1755-3768.2016.0274-j.1755-3768.2016.0274

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.94, Iss.S256, 2016-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 431-434

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 1 year outcome of intravitreal dexamethasone implant for macular edema secondary to central retinal vein occlusion

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

A United Kingdom-based economic evaluation of ranibizumab for patients with retinal vein occlusion (RVO)

By Taylor Matthew   Serbetci Elçin   Ferreira Alberto   Gairy Kerry   Lewis Lily   Blouin Julie   Mitchell Paul  

Journal of Medical Economics, Vol. 17, Iss. 6, 2014-06 ,pp. : 423-434

Informa Healthcare

Access to resources Recommend Favorite

Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti-Vascular Endothelial Growth Factors

By  

Current Drug Safety, Vol. 10, Iss. 2, 2015-07 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

Injections in retinal vein occlusions

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 650-655

John Wiley & Sons Inc

Access to resources Recommend Favorite